Phase II trial of pertuzumab and trastuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer that progressed during prior trastuzumab therapy

1. Baselga, J.
2. Gelmon, K.A.
3. Verma, S.
4. Wardley, A.
5. Conte, P.
6. Miles, D.
7. Bianchi, G.
8. Cortes, J.
9. McNally, V.A.
10. Ross, G.A.
11. Fumoleau, P.
12. Gianni, L.